Price Transparency Slowdown May Aid Strategic Response
-
Dec 10, 2021
Delays are hitting some aspects of the federal price transparency agenda — the complex web of laws, rules and regulations targeting insurers, providers and pharmacy stakeholders, among others. But policy experts say it’s not time to sit back and wait.
That’s what a panel of payer- and provider-focused insiders from the Advisory Board recommended during a Dec. 1 webinar covering federal transparency requirements for the health care sector.
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.